HomeGLMD • NASDAQ
add
Galmed Pharmaceuticals Ltd
Previous close
$0.36
Day range
$0.36 - $0.38
Year range
$0.26 - $7.80
Market cap
2.27M USD
Avg Volume
317.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.15M | -12.17% |
Net income | -2.02M | 23.61% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.14M | 12.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.64M | -8.29% |
Total assets | 16.63M | 0.41% |
Total liabilities | 2.75M | -12.36% |
Total equity | 13.88M | — |
Shares outstanding | 6.01M | — |
Price to book | 0.13 | — |
Return on assets | -31.39% | — |
Return on capital | -36.50% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.02M | 23.61% |
Cash from operations | -898.00K | 77.68% |
Cash from investing | 2.28M | 15.16% |
Cash from financing | 0.00 | — |
Net change in cash | 1.38M | 167.53% |
Free cash flow | -237.38K | 92.40% |
About
Founded
2000
Website
Employees
6